Deadline for Submission: April 13, 2026

By submitting the Claim Form, you are making a request to share in the proceeds of the Settlement described in the Settlement Notice, which is available at www.CelgeneSecuritiesLitigation.com.  If you are not a Class Member, or if you previously submitted a request for exclusion and are listed on Appendix 1 to the Stipulation and Agreement of Settlement dated November 4, 2025, you are not eligible for a payment in the Settlement.  Submission of this Claim Form does not guarantee that you will share in the proceeds of the Settlement.  The distribution of the Net Settlement Fund will be governed by the Plan of Allocation set forth in the Settlement Notice or by such other plan of allocation as the Court approves.

In Part III of the Claim Form, you must provide the requested information with respect to your holdings, purchases, acquisitions, and sales of Celgene common stock (including free transfers and deliveries), whether such transactions resulted in a profit or a loss. Failure to report all transaction and holding information during the requested time period may result in the rejection of your claim.

Documentation. You are required to submit genuine and sufficient documentation for all of your transactions in and holdings of Celgene common stock set forth in Part III of the Claim Form.  Documentation may consist of copies of account statements, transaction reports or confirmations, or any other authorized statements prepared by your broker, financial advisor, online trading platform, or other financial institution through which you purchased or held your shares of Celgene common stock. For purchases, acquisitions, and sales, the documentation must show the number of shares traded, the price paid, and the date.  A screenshot of an online trading platform that shows all of this required information and the name of the owner of the account will be acceptable.  The Parties and the Claims Administrator do not independently have information about your investments in Celgene common stock.  If such documents are not in your possession, please obtain copies of these documents for your financial institution. Self-created documents are not sufficient.  Failure to supply this documentation may result in the rejection of your claim. Please do not send original documents, as they will not be returned. Please keep a copy of all documents that you send to the Claims Administrator.

The “Owner” of the Celgene common stock should be identified in Part I of the Claim Form entitled “CLAIMANT INFORMATION.”  The Owner listed in Part 1 of the Claim Form should be the “beneficial owner” of the Celgene common stock, that is the person who ultimately controlled or benefited from ownership of the stock.  The complete name(s) of the Owner(s) must be entered. The Owner(s) must sign the Claim Form to be eligible to participate in the Settlement.  If there are joint Owners, each must sign the Claim Form and their names must appear as “Claimants” in Part I of the Claim Form.  Many investors hold their securities indirectly through a bank, broker-dealer, or other financial advisor or financial platform.  In those cases, the investor is considered the Owner, while the bank, broker or financial advisor is considered the registered owner.  The Owner(s) must sign the Claim Form.

One Claim should be submitted for each separate legal entity or separately managed account. Separate Claim Forms should be submitted for each separate legal entity (e.g., an individual should not combine his, her or their IRA transactions with transactions made solely in the individual’s name).  Generally, a single Claim Form should be submitted on behalf of one legal entity including all holdings and transactions made by that entity on one Claim Form. However, if a single person or legal entity had multiple accounts that were separately managed, separate Claims may be submitted for each such account.  The Claims Administrator reserves the right to request information on all the holdings and transactions in Celgene common stock made on behalf of a single Owner.

PLEASE NOTE:  As set forth in the Plan of Allocation, each Authorized Claimant shall receive his, her, or its pro rata share of the Net Settlement Fund.  If the prorated payment to any Authorized Claimant calculates to less than $10.00, it will not be included in the calculation, and no distribution will be made to that Authorized Claimant.